Omada Health (OMDA) CFO Steven Cook Sells $49K of Stock
Omada Health's CFO, Steven Cook, sold 2,600 shares in a planned transaction.
Reviewed by automated data checks against the source filing. How we make and check alerts
Steven Cook, Chief Financial Officer at Omada Health, Inc. ($OMDA), sold 2,600 shares at an average price of $19.02, worth about $49,452, on June 24, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $OMDA is up 21.6% after 1 week, up 10.4% after 1 month and down 5.2% to date (from the $18.60 close on Jun 24, 2026).
OMDA
Omada Health, Inc.
Key Points
- On June 24, 2026, Omada Health's CFO Steven Cook sold 2,600 shares at $19.02 each, totaling $49,452.
- Omada Health trades on NasdaqGS under the ticker OMDA, with a market cap of about $1.12 billion and a forward P/E ratio of 39.67.
- Morgan Stanley reiterated a 'buy' rating on June 22, 2026, with a $30 price target, while other analysts maintain positive views.
Get $OMDA trade alerts by text
We text you when insiders, Congress or big funds trade $OMDA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Omada Health, Inc. alert may contain errors. Disclosures
Steven Cook, the Chief Financial Officer of Omada Health, Inc. (NasdaqGS: OMDA), sold 2,600 shares of the company on June 24, 2026. The shares were sold at an average price of $19.02 each, totaling $49,452. This transaction was planned under a Rule 10b5-1 trading plan, which allows insiders to set up a schedule for selling stocks to avoid accusations of insider trading.
Insider Buying and Selling at Omada Health, Inc.
In addition to Cook's sale, Omada Health saw several other insider transactions. CEO Sean Duffy sold 2,800 shares on June 24, 2026, at $19.01 each. Craig Gracey, the Chief Accounting Officer, also sold 2,083 shares on the same day at $19.01. These sales were part of planned transactions as well.
Omada Health, Inc. Stock Up 2.3%
Shares of Omada Health traded near $20.89 on Saturday. The company, which is listed on the NasdaqGS under the ticker OMDA, has a market capitalization of approximately $1.12 billion. It has a forward P/E ratio of 39.67, indicating how much investors are willing to pay for the company's future earnings. Over the past 52 weeks, the stock has ranged from $10.28 to $26.92. Its 50-day moving average is $16.29, and the 200-day moving average is $17.15. Omada Health maintains a strong liquidity position with a current ratio of 3.92 and a quick ratio of 3.69.
Analysts Set New Price Targets
On June 22, 2026, Morgan Stanley reiterated its 'buy' rating for Omada Health, setting a price target of $30. Barclays, Citizens, and Evercore ISI Group have also maintained their 'buy' ratings in recent months, with price targets ranging from $15 to $23. The consensus among 12 analysts is a 'buy' rating, with a mean target price of $22.92.
About Omada Health
Omada Health, Inc. provides virtual care programs, focusing on cardiometabolic conditions like prediabetes, diabetes, and hypertension. The company also offers physical therapy and behavioral health support programs. Headquartered in South San Francisco, California, Omada Health works with employers, health plans, and systems to deliver its services. Led by CEO Sean P. Duffy, the company employs around 943 people and was founded in 2011.
Bottom Line
Insider transactions at Omada Health, such as those by CFO Steven Cook, are part of planned sales and don't necessarily indicate negative sentiment. Investors often watch such sales closely as part of their due diligence. Omada Health's stock, with its strong market position and analyst support, remains of interest. However, it's important to remember that these insider sales are disclosed after the fact and are part of routine filings.
Related Filing Alerts
Source: Steven Cook's Form 4 filing on $OMDA (Jun 24, 2026). Find the original filing: OMDA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts